Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 6.93% |
| FEDERAL MOGU | FDML | 6.24% |
| NATUS MEDICA | BABY | 5.55% |
| NEW ORIENTAL | EDU | 5.44% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The Financial Industry Regulatory Authority (FINRA) has cracked down on Citigroup Global Market, a unit of Citigroup Inc. ( C - Analyst Report ) and imposed a fine of $3.5 million for allegedly offering inaccurate information related to subprime residential mortgage-backed securitizations (RMBS). The company was also accused of lacking supervisory procedures as well as violating other norms related to RMBS.
The Allegations
FINRA has accused Citi of providing inaccurate performance data related to three RMBS from January 2006 to October 2007 on its website. In spite of being informed that such information were inaccurate, Citi continued to retain them until early May 2012.
Notably, RMBS issuers need to provide historical performance data for prior securitizations which include mortgage loans that are similar to those in the RMBS they are offering to investors. However, the disclosure of faulty data by Citi likely impacted investors’ assessment as they used such inaccurate data to gauge the value of RMBS.
Moreover, Citi has also been alleged of lacking a proper supervisory procedure for verifying the pricing of these RMBS and failing to document steps for assessing whether trader’s prices were reasonable or not. Citi, also, did not supposedly maintain the required books and records when re-pricing of mortgage backed securities were made following margin calls.
Our Take
Post financial crisis, regulators have intensified their scrutiny in the mortgage market and have come up with charges against the big shots for their fraudulent practices. In fact, besides Citi, other majors who could not escape FINRA’s wrath and were imposed penalties related to similar issues include Barclays Plc. ( BCS - Snapshot Report ) as well as Deutsche Bank AG ( DB - Snapshot Report ) . They have been accused of misinterpreting delinquency data related to RMBS.
Notably, Citi has hit headlines in the past couple of years for issues related to its faulty procedures associated with the mortgage business. The company was subject to a penalty of $75 million in 2010 by the Securities and Exchange Commission for misleading its investors about its exposure to subprime mortgage-related assets. We believe such penalties not only dent the company’s financial but also blemish its reputation.
Citi currently retains its Zacks #3 Rank, which translates to a short-term Hold rating. Considering the fundamentals, we also maintain a long-term Neutral recommendation on the stock.
Read the full Analyst Report on C
Read the full Snapshot Report on BCS
Read the full Snapshot Report on DB